Spain· ES:85319
ABACAVIR ACCORD 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
A abacavir product containing abacavir, registered in Spain by Accord Healthcare S.L.U.. The same ATC class is registered in 16 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Abacavir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AF06 (abacavir), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 10 of them publish a price we can compare per daily dose
Abacavir · ATC J05AF06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abacavir costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $3.98 in France to $9.36 in Switzerland — a ×2.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Abacavir · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.36
- FR France$3.98
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- abacavir
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Spain (ES)
- ATC code
- J05AF06
- ATC class
- Abacavir
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- August 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
131 interactions on record for abacavir.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Abacavir · interactions on record
131 records
- 4 severe
- 23 moderate
- 6 minor
- 96 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Abacavir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAbacavirMajor Pharmaceuticals
- BelgiumAbacavir Sandoz 300 mgSandoz
- FinlandAbacavir AccordAccord Healthcare B.V.
- FranceABACAVIR ARROW 300 mg, comprimé pelliculé sécableARROW GENERIQUES
- NetherlandsAbacavir Accord 300 mg, filmomhulde tablettenAccord Healthcare B.V.
- PolandAbacavir AccordAccord Healthcare Polska Sp. z o.o.
- SwedenAbacavir Accord 300 mg Filmdragerad tablettAccord Healthcare B.V.
- NorwayZiagenViiV Healthcare BV (1)
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Finland · Abacavir Accord
- France · Abacavir Arrow, Abacavir Sandoz
- United Kingdom (Northern Ireland) · Abacavir Milpharm, Abacavir Mylan
- Iceland · Ziagen
- Italy · Abacavir Mylan
- Liechtenstein · Ziagen
- Netherlands · Abacavir Accord, Abacavir Sandoz
- Norway · Ziagen
- Portugal · Abacavir Farmoz, Abacavir Generis
- Romania · Abacavir Aurobindo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f5ad2be-8eab-4667-a937-ac53f6892902 GET /v1/drugs/6f5ad2be-8eab-4667-a937-ac53f6892902?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1596664800000,\"rev\":1748254928000}",
"nregistro": "85319",
"substance": "abacavir"
}See everything about abacavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.